EUVIMEDEUVIMED entdecken
Crossref

Body Adiposity as a Risk Factor for Portal Vein Thrombosis in Patients With Cirrhosis

Isabel Campos-Varela iD, Carlos Cespedes iD, Sergi Quiroga iD, Ester Palacio iD, Monica Pons iD, Nuria Roson iD, Jennifer L Dodge iD, Elena Vargas-Accarino iD, Cristina Dopazo iD, Guillermo Cardenas iD, Victor Vargas iD, Lluis Castells iD und 1 weitere

Liver International · 2026-12 · 46 (12)

DOI: 10.1111/liv.70941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 04.11.2026. Verfasst von Isabel Campos-Varela und 12 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Department of Medicine, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron Barcelona Hospital …. Hauptthemen laut MEDLINE: Adiposity, Venous Thrombosis, Portal Vein, Liver Cirrhosis. Die Arbeit nennt 50 Literaturangaben. Gefördert von: SCIII, CIBERHED, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Adipose tissue alterations are linked to adverse outcomes in patients with cirrhosis, but their role in portal vein thrombosis (PVT) is unclear. We aimed to evaluate the association between body composition and PVT.

Methods

Cross‐sectional study including patients with cirrhosis. Body adiposity was assessed by computed tomography (CT) at the third lumbar vertebra including visceral (VATI), subcutaneous (SATI) and total adipose (TATI) tissue indexes, bioimpedance analysis (BIA) including visceral fat area (VFA), total body fat (TBF) and total body fat percentage (TBF%), and anthropometry.

Results

In total, 245 patients with cirrhosis (median age 62 years, 74% male) were included, 17% with PVT. Adiposity was generally higher for PVT versus non‐PVT groups but was only significant for BIA‐derived TBF [median 25.5 kg (IQR 17.9–35.5) vs. 21.4 (15.1–30.5), p = 0.05]. In logistic regression models adjusted for sex, smoking, spleen size and Child‐Pugh score, PVT was associated with higher adiposity by BIA‐derived measures (aOR per standard deviation increase: TBF 1.52, 95% CI 1.09–2.11; p = 0.01; TBF% 1.47, 95% CI 1.01–2.14; p = 0.04; VFA 1.41, 95% CI 1.01–1.97; p = 0.047), CT‐derived TATI (aOR per standard deviation increase: 1.44, 95% CI 1.02–2.05; p = 0.04) and anthropometry (aOR per standard deviation increase: waist circumference 1.44, 95% CI 1.01–2.08; p = 0.049; hip circumference 1.48, 95% CI 1.04–2.12; p = 0.03). Larger spleen size was consistently associated with a 46%–57% increase (per standard deviation) in likelihood of PVT across models (all p < 0.05).

Conclusion

PVT was associated with both greater adiposity and larger spleen size, suggesting that, in addition to portal hypertension, adiposity may be a risk factor for PVT development through an inflammatory/prothrombotic role among patients with cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdiposityVenous ThrombosisPortal VeinLiver CirrhosisHumansMaleCross-Sectional StudiesMiddle AgedFemaleRisk FactorsTomography, X-Ray ComputedAgedLogistic ModelsIntra-Abdominal FatElectric Impedance

Stichwörter der Autor:innen

bioelectrical impedance analysisbody compositionportal hypertensionsubcutaneous adipose tissue indexvisceral adipose tissue index

Autor:innen und Institutionen

  • Liver Unit, Department of Medicine, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
  • European Reference Network on Hepatological Diseases (ERN RARE-LIVER).
  • Radiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Medicine, Keck Medicine of USC, California, Los Angeles, USA.
  • Department of Population and Public Health Science, Keck Medicine of USC, California, Los Angeles, USA.

ORCID-Profile: Isabel Campos-Varela, Carlos Cespedes, Sergi Quiroga, Ester Palacio, Monica Pons, Nuria Roson, Jennifer L Dodge, Elena Vargas-Accarino, Cristina Dopazo, Guillermo Cardenas, Victor Vargas, Lluis Castells, Macarena Simon-Talero

Förderung

  • SCIII
  • CIBERHED
  • Instituto de Salud Carlos III

Zitieren

APA

Campos-Varela, I., Cespedes, C., Quiroga, S., Palacio, E., Pons, M., Roson, N., Dodge, J. L., Vargas-Accarino, E., Dopazo, C., Cardenas, G., Vargas, V., Castells, L., & Simon-Talero, M. (2026). Body Adiposity as a Risk Factor for Portal Vein Thrombosis in Patients With Cirrhosis. Liver International, 46(12). https://doi.org/10.1111/liv.70941

Vancouver

Campos-Varela I, Cespedes C, Quiroga S, Palacio E, Pons M, Roson N, et al. Body Adiposity as a Risk Factor for Portal Vein Thrombosis in Patients With Cirrhosis. Liver International. 2026;46(12). doi:10.1111/liv.70941

BibTeX
@article{CamposVarela2026,
  author = {Campos-Varela, Isabel and Cespedes, Carlos and Quiroga, Sergi and Palacio, Ester and Pons, Monica and Roson, Nuria and Dodge, Jennifer L and Vargas-Accarino, Elena and Dopazo, Cristina and Cardenas, Guillermo and Vargas, Victor and Castells, Lluis and Simon-Talero, Macarena},
  title = {Body Adiposity as a Risk Factor for Portal Vein Thrombosis in Patients With Cirrhosis},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {12},
  doi = {10.1111/liv.70941}
}
Kostenlos starten →